Search

Zai Lab Ltd ADR

Atidarymo kaina

SektoriusSveikatos priežiūra

24.59 -0.61

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

24.56

Max

25.29

Pagrindiniai rodikliai

By Trading Economics

Pajamos

191K

-51M

Pardavimai

6.7M

106M

Pelnas, tenkantis vienai akcijai

-0.46

Pelno marža

-47.808

Darbuotojai

1,784

EBITDA

-2.1M

-46M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+58.6% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-05

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

737M

2.8B

Ankstesnė atidarymo kaina

25.2

Ankstesnė uždarymo kaina

24.59

Naujienos nuotaikos

By Acuity

38%

62%

84 / 339 reitingas Healthcare

Zai Lab Ltd ADR Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-15 23:56; UTC

News

Lululemon Athletica shares are lower in after-market hours amid an investigation into potential securities law violations following a revenue guidance cut.

2026-09-15 23:41; UTC

Correlated Moves
News

Heartland Express shares are lower in after-market trading, influenced by declines in Schneider National and concerns from the New York Empire State Manufacturing Index.

2026-09-15 23:41; UTC

Correlated Moves
News

Tower Semiconductor shares are lower in after-market hours amid broader market dynamics and rising treasury yields ahead of the Federal Reserve's policy decision.

2026-09-15 23:31; UTC

News

Xylem Inc. shares declined in after-market hours following a $1.5 billion senior notes offering, reflecting broader market trends and shifting investor sentiment.

2026-09-15 23:26; UTC

News

Phil Poliquin has been appointed senior vice president at United Bankshares, focusing on government contracting. Shares are roughly flat in after-market trading.

2026-09-15 23:16; UTC

News

FedEx shares are lower in after-market trading following the appointment of Mike Rodgers as Chief Commercial and Technology Officer amid broader market pressure.

2026-09-15 23:16; UTC

News

Royalty Pharma announced a $7.5 million donation to Blood Cancer United. Shares are lower in after-market trading amid rising Treasury yields.

2026-09-15 23:11; UTC

News

Coca-Cola Europacific Partners PLC gains in after-market hours on a planned $10 billion investment in U.S. infrastructure through 2030, focusing on production and distribution.

2026-09-15 23:06; UTC

News

FuelCell Energy shares rise in after-hours trading following insider purchases. Director John Livingston bought 26.3K shares for $247K on September 14.

2026-09-15 23:06; UTC

News

Apple Inc. shares rose in after-market trading following a product event that introduced new offerings and received an "Overweight" rating from Morgan Stanley with a $360 target.

2026-09-15 23:06; UTC

Correlated Moves
News

Blackstone Inc's shares are higher in after-market trading, likely influenced by KKR & Co Inc's recovery and recent IPO activity highlighted by CFO Michael Chae.

2026-09-15 23:06; UTC

News

UnitedHealth Group will release third quarter 2026 results on October 13. Shares are trading higher in after-market hours, reflecting a modest gain.

2026-09-15 23:06; UTC

News

Intuit Inc reported full-year revenue of $21.4 billion, a 14% increase. Shares are higher in after-market trading following the results and positive sentiment.

2026-09-15 23:02; UTC

News

Walmart shares rose in after-market trading following a 5.1% growth in global enterprise, surpassing its average target and reflecting strong consumer spending.

2026-09-15 23:02; UTC

News

Permian Resources shares are higher in after-market trading, with a current price of $24.49, reflecting strong long-term performance and a market cap of $20.51 billion.

2026-09-15 23:02; UTC

News
Social Media

RTX shares are higher in after-market trading following the appointment of Jill Albertelli as president of Pratt & Whitney, effective January 1, 2027.

2026-09-15 23:02; UTC

Correlated Moves
News

Chevron Corp shares are lower in after-market hours, influenced by a drop in the New York Empire State Manufacturing Index and ongoing supply risks.

2026-09-15 23:02; UTC

News
Event

Trip.com Group Ltd reported second-quarter EPS of $1.07, exceeding expectations, while shares rose in after-market trading following the earnings announcement.

2026-09-15 23:02; UTC

News

Target Corp shares are trading higher in after-market hours following the announcement of a new employee apparel line designed by Isaac Mizrahi.

2026-09-15 23:02; UTC

Social Media
News

Celsius Holdings Inc. shares rose in after-hours trading following significant insider purchases totaling around $1 million by Director Damon DeSantis.

2026-09-15 23:02; UTC

Correlated Moves
News

Qualcomm's after-market trading remains stable, reflecting Nasdaq 100 trends. The company reported $9.9 billion in revenue for the fiscal third quarter.

2026-09-15 23:02; UTC

News

CrowdStrike Holdings shares are lower in after-market hours amid negative sentiment following a sharp decline in the New York Empire State Manufacturing Index.

2026-09-15 23:02; UTC

News

Radiant Logistics shares are higher in after-market trading despite Glencore's $2 billion lawsuit alleging fraud and terminating business relationships with Radiant World.

2026-09-15 23:02; UTC

Correlated Moves
News

Coinbase Global shares are lower in after-hours trading, influenced by declines in Bitcoin and Bitmine Immersion Technologies, amid a weak overall trading environment.

2026-09-15 23:01; UTC

News

Boeing's recent Pentagon agreements include a $13.4 billion expansion of the KC-46 contract, though shares traded roughly flat in after-market hours.

2026-09-15 23:01; UTC

News
Event

Evolution Petroleum shares are higher after reporting fourth-quarter revenue of $24.21 million, exceeding expectations, though adjusted EPS missed consensus estimates.

2026-09-15 23:01; UTC

News

Interactive Brokers Group has integrated with X Cashtags, enabling US users to trade directly from tagged stock and crypto symbols. Shares are higher in after-market hours.

2026-09-15 23:01; UTC

News

D.R. Horton announced a $5 billion stock repurchase program and raised its fiscal 2026 buyback target to $3.25 billion, contributing to after-market gains.

2026-09-15 23:01; UTC

News

Alignment Healthcare Inc. shares are lower in after-market hours as bipartisan lawmakers introduce the Protecting Approved Care Act, impacting Medicare Advantage plans.

2026-09-15 23:01; UTC

News

Coca-Cola Co plans a $10 billion investment in U.S. infrastructure by 2030. Shares showed little change during after-market hours, reflecting stable trading conditions.

Akcijų palyginimas

Kainos pokytis

Zai Lab Ltd ADR Prognozė

Kainos tikslas

By TipRanks

58.6% į viršų

12 mėnesių prognozė

Vidutinis 39.333 USD  58.6%

Aukščiausias 45 USD

Žemiausias 36 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Zai Lab Ltd ADR kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

84 / 339 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat